Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Abraxis Biosciences, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Abraxis Biosciences, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Abraxis Biosciences, Inc. since 2005.
The reporting company's ticker symbol is ABII. The reporting company's CIK number is 1409012.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $152,710.
The total value of stock option exercises since 2005 is $1,300,641.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2010-10-15||Artistry Acquisition Corp. (10% Owner)||Buy||40,735,300||.00||0|
|2010-02-24||Soon Shiong Patrick (Executive Chairman)||Option Ex||165,476||7.86||1,300,641|
|2009-11-10||Wendel Bruce (Exec. VP Corporate Development)||Sale||797||35.42||28,229|
|2009-03-02||Geehr Ed (Executive VP Operations)||Option Ex||920||.00||0|
|2009-03-02||O'toole David D. (CFO & Executive VP)||Option Ex||866||.00||0|
|2009-03-02||Wendel Bruce (Exec. VP Corporate Development)||Option Ex||920||.00||0|
|2009-03-02||Soon Shiong Patrick (Chairman and CEO)||Option Ex||2,045||.00||0|
|2008-06-06||Chen David (Director)||Sale||1,875||66.39||124,481|
Insider trading activities including stock purchases, stock sales, and option exercises of ABII listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Abraxis Biosciences, Inc. (symbol ABII, CIK number 1409012) see the Securities and Exchange Commission (SEC) website.